Company news
Rohto Pharmaceutical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Notice Regarding Partial Corrections to “Medium- to Long-Term Growth Strategy 2026”
October 5, 2026
Medium- to Long-Term Growth Strategy 2026,October 5, 2026
October 5, 2026
Medium- to Long-Term Growth Strategy 2026
October 1, 2026
Management Strategy Briefing
October 1, 2026
バージャー病、膠原病により生じる難治性虚血性（非動脈硬化性）下肢潰瘍に対するRE-01細胞治療の第II相医師主導治験を開始
September 15, 2026
Notice Regarding the Status of Repurchase of Shares and Completion of Repurchase
September 15, 2026
Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
September 1, 2026
Notice Regarding the Status of Repurchase of Shares
September 1, 2026
Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States
August 10, 2026
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)
August 6, 2026
【Delayed】Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023
August 18, 2022
Rohto Pharmaceutical: Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022
February 17, 2022
Rohto Pharmaceutical: Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022
November 18, 2021
Rohto Pharmaceutical: Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022
August 18, 2021
Rohto Pharmaceutical: Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
May 21, 2021
Rohto Pharmaceutical: Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2021
August 12, 2020
Decks
- ロート製薬 — Investor Day (October 2026)
Investor day · 48 slides · Oct 2, 2026
- Proxy Contest (April 2026)
Proxy contest · 75 slides · Apr 30, 2026